课题基金 / 基金详情

Physiological significance of human placental aminopeptidases

Physiological significance of human placental aminopeptidases
人胎盘氨肽酶的生理意义
批准号:
05454444
负责人:
MIZUTANI Shigehiko
金额:
$3.97万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1995

项目摘要

项目成果

MIZUTANI Shigehiko的其他基金

相似基金

相关文献

中文摘要
翻译
我们试图通过胎盘中生物活性肽激素及其降解蛋白酶的相互关系来了解妊娠的病理生理。研究结果表明:(1)从人胎盘cDNA文库中分离到一个编码P-LAP的4084个碱基对的cDNA克隆。推导出的序列在N端附近包含一个疏水区,表明该酶是II型积分膜蛋白。(2)人胎盘中催产素和抗利尿素降解蛋白酶为P-LAP。(3)人胎盘中生长抑素降解蛋白酶为P-LAP。P-LAP可能不仅通过调节生长抑素的浓度,还通过调节胎儿胎盘循环中的血管活性肽(如血管加压素)的浓度参与胎儿的发育。(4)人胎盘血管紧张素II降解的起始蛋白酶为氨基肽酶A和氨基肽酶N (AP-N)。(5)胎盘AP-N (CD13)降解免疫调节肽,如簇状肽、胸腺喷肽和脾喷肽。AP-N可能通过调节免疫调节肽的浓度参与妊娠免疫。临床研究结果表明:(1)随着妊娠的推进,血清中氨基肽酶P增高,而氨基肽酶P可降解缓激肽。(2) P-LAP可用于监测产后妊娠和早产。(3)我们发现正常妊娠时脉冲多普勒S/D比值与P-LAP活性有显著相关性。妊娠血清P-LAP活性可能通过调节胎儿血管抑制素的浓度来反映脐动脉血管阻力。
英文摘要
We tried to understand pathophysiology in pregnancy via interrelationship between bioactive peptide hormones and their degradation proteases in placenta.1. Basic Research We showed the following evidences :(1) We isolated a cDNA clone with 4084 base pairs encoding P-LAP from a human placental cDNA library. The deduced suquence contains a hydrophobic region near the N terminus, suggesting that the enzyme is a type II intergral membrane protein.(2) The oxytocin and vasopressin degradation protease in human placenta is P-LAP.(3) The somatostatin degradation protease in human placenta is P-LAP.P-LAP might be involved in the development of the fetus via regulation not only the concentration of somatostatin but also vasoactive peptides such as vasopressin in the feto-placental circulation.(4) The initiating protease of angiotensin II degradation in human placental in aminopeptidase A and aminopeptidase N (AP-N).(5) Placental AP-N (CD13) degrades immunomodulating peptides such as tuftsin, thymopentin and splenopentin. AP-N might be involved in the immunology of pregnancy via regulating the concentration of immunomodulating peptides.2. Clinical Research We showed the following evidences :(1) Aminopepidase P,which might degrade bradykinin, increases in pregnancy sera with advancing gestation.(2) P-LAP in useful for monitoring post date pregnancy and premature delivery.(3) We found the significant correlation between pulsed Doppler S/D ratio and P-LAP activity in normal pregnancy. The P-LAP activity in pregnancy sera might reflect the vascular resistance in umbilical artery via regulation the concentration of fetal vasopression.
期刊论文(174)
专著(0)
科研奖励(0)
会议论文
八神博史: "Catheter-tip transducerを使った卵膜外子宮内圧測定法." 日産婦誌. 45. 1399-1403 (1993)
Hiroshi Yagami:“使用导管尖端传感器的鞘外子宫内压力测量方法。”Nissan Gynecology 45. 1399-1403 (1993)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T.Rogi: "Human placental leucine aminopeptidase/Oxytocinase A new member of type II membrane-spanning zinc metalloptidase family" J.Biol.Chem.271. 56-61 (1996)
T.Rogi:“人胎盘亮氨酸氨肽酶/催产素酶是 II 型跨膜锌金属优化酶家族的新成员”J.Biol.Chem.271。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
水谷栄彦: "産婦人科Clinical Data胎盤酵素" 産と婦 増刊号. 14-16 (1993)
Eihiko Mizutani:“妇产科临床数据胎盘酶”妇产科和妇女特刊 14-16 (1993)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
H.Yagami: "Expression of angiotensin converting enzyme in human placenta and its physiologic role in the fetal circulation." Obstet.Gynecol.84. 453-457 (1994)
H.Yagami:“血管紧张素转换酶在人胎盘中的表达及其在胎儿循环中的生理作用。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
54
    Physiological roles of placental leucine aminopeptidase/oxytocinase and its clinical application using molecular biological technique.
    • 批准号:
      12470341
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $5.5万
    • 财政年份:
      2000
    • 负责人:
      MIZUTANI Shigehiko
    • 依托单位:
    physiological significance of placental aminopeptidases
    • 批准号:
      02454378
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $4.48万
    • 财政年份:
      1990
    • 负责人:
      MIZUTANI Shigehiko
    • 依托单位:
    The etiology of pregnancy-induced hypertension based on the degradation of angiotensin II by placental aminopeptidases
    • 批准号:
      61570787
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.47万
    • 财政年份:
      1986
    • 负责人:
      MIZUTANI Shigehiko
    • 依托单位:
    国内基金
    海外基金
    Oxytocin通过MAPK/ERK信号通路调控血管平滑肌细胞表型转换在颅内动脉瘤发生发展中的作用及相关分子机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      王刚
    • 依托单位:
    Oxytocin在社交响应及免疫调节中的协同作用及机制研究
    • 批准号:
      81870949
    • 项目类别:
      面上项目
    • 资助金额:
      56.0万元
    • 批准年份:
      2018
    • 负责人:
      景玉宏
    • 依托单位: